Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma in a Kidney Transplant Recipient

Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma in a Kidney Transplant Recipient

Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy is a newer and effective therapeutic option approved for patients with relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma. Acute kidney injury is a complication of CAR T-cell therapy that can result in kidney fa...

Full description

Bibliographic Details
Main Authors: Edoardo Melilli, Alberto Mussetti, Gabriela Sanz Linares, Marco Ruella, Charette La Salette, Alexandre Savchenko, Maria del Rosario Taco, Nuria Montero, Josep Grinyo, Alex Fava, Montse Gomà, Maria Meneghini, Anna Manonelles, Josepmaria Cruzado, Ana Sureda, Oriol Bestard
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Kidney Medicine
Subjects:
PTLD
posttransplant lymphoproliferative disorder
kidney transplant
T-cell therapy
B-cell lymphoma
Online Access:http://www.sciencedirect.com/science/article/pii/S2590059521001011

Internet

http://www.sciencedirect.com/science/article/pii/S2590059521001011

Similar Items